C. Barillà

435 total citations
9 papers, 105 citations indexed

About

C. Barillà is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Molecular Biology. According to data from OpenAlex, C. Barillà has authored 9 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Electrical and Electronic Engineering and 3 papers in Molecular Biology. Recurrent topics in C. Barillà's work include Energy Harvesting in Wireless Networks (4 papers), Cystic Fibrosis Research Advances (4 papers) and Neonatal Respiratory Health Research (3 papers). C. Barillà is often cited by papers focused on Energy Harvesting in Wireless Networks (4 papers), Cystic Fibrosis Research Advances (4 papers) and Neonatal Respiratory Health Research (3 papers). C. Barillà collaborates with scholars based in United States, Italy and Japan. C. Barillà's co-authors include Shingo Suzuki, Brian R. Davis, Scott H. Randell, András Rab, Finn Hawkins, Eric J. Sorscher, Matthew Mendel, Shiyi Yin, Anthony Conway and Ana M. Crane and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Therapy.

In The Last Decade

C. Barillà

8 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Barillà United States	4	66	61	28	13	9	9	105
Jesse E. Brunsveld Netherlands	4	50 0.8×	95 1.6×	10 0.4×	31 2.4×	9 1.0×	5	145
E. Wierzbicka-Hainaut France	7	8 0.1×	18 0.3×	11 0.4×	5 0.4×	6 0.7×	19	78
Taylor Liu United States	6	7 0.1×	38 0.6×	7 0.3×	16 1.2×	7 0.8×	11	138
Pankti Shah United States	6	7 0.1×	19 0.3×	15 0.5×	13 1.0×	5 0.6×	9	54
Pragya Sidhwani United States	5	8 0.1×	71 1.2×	4 0.1×	5 0.4×	6 0.7×	5	84
Elizabeth M. Chun United States	3	9 0.1×	43 0.7×	3 0.1×	3 0.2×	3 0.3×	6	67
Werhner Orilla United States	7	11 0.2×	53 0.9×	2 0.1×	4 0.3×	3 0.3×	16	382
Rustin Massoudi United States	4	7 0.1×	40 0.7×	9 0.3×	35 2.7×	4 0.4×	7	76
Anne‐Sophie Denommé‐Pichon France	5	3 0.0×	43 0.7×	5 0.2×	21 1.6×	11 1.2×	12	81
Magdalene Yin Lin Ting United Kingdom	3	42 0.6×	14 0.2×		23 1.8×	12 1.3×	9	77

Countries citing papers authored by C. Barillà

Since Specialization

Citations

This map shows the geographic impact of C. Barillà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Barillà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Barillà more than expected).

Fields of papers citing papers by C. Barillà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Barillà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Barillà. The network helps show where C. Barillà may publish in the future.

Co-authorship network of co-authors of C. Barillà

This figure shows the co-authorship network connecting the top 25 collaborators of C. Barillà. A scholar is included among the top collaborators of C. Barillà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Barillà. C. Barillà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hunt, William R., Candela Manfredi, Jeong S. Hong, et al.. (2025). Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol. PLoS ONE. 20(2). e0316721–e0316721.

Solomon, George M., Rachel W. Linnemann, Eric Hunter, et al.. (2024). Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial. The Lancet Respiratory Medicine. 12(12). 947–957. 6 indexed citations

Barillà, C., Shingo Suzuki, András Rab, Eric J. Sorscher, & Brian R. Davis. (2022). Targeted Gene Insertion for Functional CFTR Restoration in Airway Epithelium. SHILAP Revista de lepidopterología. 4. 847645–847645. 2 indexed citations

Suzuki, Shingo, C. Barillà, Michael Yao, et al.. (2022). Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events. SHILAP Revista de lepidopterología. 4. 843885–843885. 2 indexed citations

Suzuki, Shingo, Finn Hawkins, C. Barillà, et al.. (2021). Differentiation of human pluripotent stem cells into functional airway basal stem cells. STAR Protocols. 2(3). 100683–100683. 12 indexed citations

Barillà, C., Samuel Suzuki, András Rab, et al.. (2021). 667: Development of an iPSC-based airway epithelial platform for evaluating patient-specific responses to modulators. Journal of Cystic Fibrosis. 20. S316–S316. 1 indexed citations

Linnemann, Rachel W., George M. Solomon, William B. Driggers, et al.. (2021). 572: Clinical and iPSC-derived airway epithelial responses to elexacaftor/tezacaftor/ivacaftor in CF patients without an approved modulator. Journal of Cystic Fibrosis. 20. S271–S271. 1 indexed citations

Suzuki, Shingo, Ana M. Crane, C. Barillà, et al.. (2020). Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction. Molecular Therapy. 28(7). 1684–1695. 60 indexed citations

Suzuki, Shingo, C. Barillà, Finn Hawkins, et al.. (2020). Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis. Human Gene Therapy. 31(17-18). 956–972. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact